Raised charges and Covax deals on order books of Pfizer, BioNTech, Moderna and AstraZeneca
Two US companies, Pfizer and Moderna, have raised the prices of their Covid-19 vaccines after data from clinical trials showed their mRNA formula was more effective than cheaper vaccines from Britain’s AstraZeneca and the American drugs maker Johnson & Johnson.
AstraZeneca and Johnson & Johnson have pledged to provide their doses on a not-for-profit basis until the pandemic ends.
Related: UK orders extra Covid vaccines for autumn 2022 booster campaign
